King Luther Capital Management Corp Eli Lilly & CO Transaction History

King Luther Capital Management Corp

$23 Billion
Q3 2024

A detailed history of King Luther Capital Management Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, King Luther Capital Management Corp holds 133,682 shares of LLY stock, worth $101 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

133,682

Previous 129,181 3.48%

Holding current value

$101 Million

Previous $117 Million 1.26%

% of portfolio

0.52%

Previous 0.53%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$772.14 - $960.02 $3.48 Million - $4.32 Million	4,501 Added 3.48%	133,682 $118 Million
Q2 2024 Aug 12, 2024	BUY	$724.87 - $909.04 $1.74 Million - $2.18 Million	2,397 Added 1.89%	129,181 $117 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $7.51 Million - $10 Million	12,677 Added 11.11%	126,784 $98.6 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $15.5 Million - $18.2 Million	29,443 Added 34.78%	114,107 $66.5 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $16.9 Million - $23.4 Million	38,970 Added 85.28%	84,664 $45.5 Million
Q2 2023 Aug 10, 2023	BUY	$350.74 - $468.98 $5.53 Million - $7.4 Million	15,772 Added 52.71%	45,694 $21.4 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $342,314 - $402,031	1,102 Added 3.82%	29,922 $10.3 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $961,434 - $1.12 Million	2,990 Added 11.58%	28,820 $10.5 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $299,148 - $340,910	-1,009 Reduced 3.76%	25,830 $8.35 Million
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $437,327 - $513,486	1,569 Added 6.21%	26,839 $8.7 Million
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $27,458 - $34,124	-117 Reduced 0.46%	25,270 $7.24 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $190,897 - $236,904	849 Added 3.46%	25,387 $7.01 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $91,520 - $112,629	-413 Reduced 1.66%	24,538 $5.67 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $1.45 Million - $1.88 Million	-8,058 Reduced 24.41%	24,951 $5.73 Million
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $18,075 - $23,399	-110 Reduced 0.33%	33,009 $6.17 Million
Q4 2020 Feb 10, 2021	SELL	$130.46 - $172.63 $134,634 - $178,154	-1,032 Reduced 3.02%	33,119 $5.59 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $1,754 - $2,029	12 Added 0.04%	34,151 $5.06 Million
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $79,805 - $96,045	-585 Reduced 1.68%	34,139 $5.61 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $285,243 - $353,050	-2,396 Reduced 6.45%	34,724 $4.82 Million
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $111,731 - $138,389	1,045 Added 2.9%	37,120 $4.88 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $109,139 - $118,715	-1,022 Reduced 2.75%	36,075 $4.03 Million
Q2 2019 Aug 12, 2019	BUY	$110.79 - $129.32 $17,726 - $20,691	160 Added 0.43%	37,097 $4.11 Million
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $223,955 - $263,612	-2,012 Reduced 5.17%	36,937 $4.79 Million
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $72,329 - $81,031	683 Added 1.78%	38,949 $4.51 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $19,833 - $24,788	231 Added 0.61%	38,266 $4.11 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $18,395 - $21,111	-243 Reduced 0.63%	38,035 $3.25 Million
Q1 2018 May 08, 2018	SELL	$74.21 - $87.6 $37,476 - $44,238	-505 Reduced 1.3%	38,278 $2.96 Million
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $125,286 - $134,383	1,529 Added 4.1%	38,783 $3.28 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $2.87 Million - $3.19 Million	37,254	37,254 $3.19 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.

Account

King Luther Capital Management Corp Eli Lilly & CO Transaction History